These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 3516430)
1. Pharmacokinetics of high-dose intravenous melphalan in children and adults with forced diuresis. Report in 26 cases. Ardiet C; Tranchand B; Biron P; Rebattu P; Philip T Cancer Chemother Pharmacol; 1986; 16(3):300-5. PubMed ID: 3516430 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of high-dose melphalan in children and adults. Gouyette A; Hartmann O; Pico JL Cancer Chemother Pharmacol; 1986; 16(2):184-9. PubMed ID: 3948304 [TBL] [Abstract][Full Text] [Related]
3. High dose melphalan in children with advanced malignant disease. A pharmacokinetic study. Ninane J; Baurain R; de Selys A; Trouet A; Cornu G Cancer Chemother Pharmacol; 1985; 15(3):263-7. PubMed ID: 4053270 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of melphalan in children following high-dose intravenous injection. Taha IA; Ahmad RA; Rogers DW; Pritchard J; Rogers HJ Cancer Chemother Pharmacol; 1983; 10(3):212-6. PubMed ID: 6861266 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of oral and intravenous melphalan during routine treatment of multiple myeloma. Bosanquet AG; Gilby ED Eur J Cancer Clin Oncol; 1982 Apr; 18(4):355-62. PubMed ID: 6889512 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of high dose melphalan. Hersh MR; Ludden TM; Kuhn JG; Knight WA Invest New Drugs; 1983; 1(4):331-4. PubMed ID: 6678879 [TBL] [Abstract][Full Text] [Related]
16. High-dose cyclophosphamide or melphalan with escalating doses of mitoxantrone and autologous bone marrow transplantation for refractory solid tumors. Mulder PO; Sleijfer DT; Willemse PH; de Vries EG; Uges DR; Mulder NH Cancer Res; 1989 Aug; 49(16):4654-8. PubMed ID: 2545349 [TBL] [Abstract][Full Text] [Related]
17. [Pharmacokinetics of high-dose melphalan (200 mg/m2) in a case of total renal insufficiency]. Tranchand B; Biron P; Mercatello A; Philip T; Ardiet C Bull Cancer; 1988; 75(3):291-6. PubMed ID: 2453234 [TBL] [Abstract][Full Text] [Related]
18. Intensive melphalan chemotherapy and cryopreserved autologous bone marrow transplantation for the treatment of refractory cancer. Lazarus HM; Herzig RH; Graham-Pole J; Wolff SN; Phillips GL; Strandjord S; Hurd D; Forman W; Gordon EM; Coccia P J Clin Oncol; 1983 Jun; 1(6):359-67. PubMed ID: 6366139 [TBL] [Abstract][Full Text] [Related]
19. Marrow autotransplantation accelerates haematological recovery in patients with malignant melanoma treated with high-dose melphalan. McElwain TJ; Hedley DW; Burton G; Clink HM; Gordon MY; Jarman M; Juttner CA; Millar JL; Milsted RA; Prentice G; Smith IE; Spence D; Woods M Br J Cancer; 1979 Jul; 40(1):72-80. PubMed ID: 383125 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of buthionine sulfoximine (NSC 326231) and its effect on melphalan-induced toxicity in mice. Smith AC; Liao JT; Page JG; Wientjes MG; Grieshaber CK Cancer Res; 1989 Oct; 49(19):5385-91. PubMed ID: 2766304 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]